Literature DB >> 15371450

Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B.

Regine Potthast1, Sarah E Abbey-Hosch, Laura K Antos, Jonathan S Marchant, Michaela Kuhn, Lincoln R Potter.   

Abstract

C-type natriuretic peptide binding to natriuretic peptide receptor-B (NPR-B) stimulates cGMP synthesis, which regulates vasorelaxation, cell proliferation, and bone growth. Here, we investigated the mechanistic basis for hyperosmotic and lysophosphatidic acid-dependent inhibition of NPR-B. Whole cell cGMP measurements and guanylyl cyclase assays indicated that acute hyperosmolarity decreased NPR-B activity in a reversible, concentration- and time-dependent manner, whereas chronic exposure had no effect. Acute hyperosmolarity elevated intracellular calcium in a concentration-dependent fashion that paralleled NPR-B desensitization. A calcium chelator, but not a protein kinase C inhibitor, blocked both calcium elevations and desensitization. Hyperosmotic medium stimulated NPR-B dephosphorylation, and the receptor was rapidly rephosphorylated and resensitized when the hypertonic media was removed. Lysophosphatidic acid also inhibited NPR-B in a calcium- and phosphorylation-dependent process, consistent with calcium being a universal regulator of NPR-B. The absolute requirement of dephosphorylation in this process was demonstrated by showing that a receptor with glutamates substituted at all known NPR-B phosphorylation sites is unresponsive to hyperosmotic stimuli. This is the first study to measure the phosphorylation state of an endogenous guanylyl cyclase and to link intracellular calcium elevations with its dephosphorylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371450     DOI: 10.1074/jbc.M408247200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

2.  Antibody tracking demonstrates cell type-specific and ligand-independent internalization of guanylyl cyclase a and natriuretic peptide receptor C.

Authors:  Deborah M Dickey; Darcy R Flora; Lincoln R Potter
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

3.  Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.

Authors:  Andrea R Yoder; Matthew D Stone; Timothy J Griffin; Lincoln R Potter
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

4.  Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.

Authors:  Jeremy R Egbert; Leia C Shuhaibar; Aaron B Edmund; Dusty A Van Helden; Jerid W Robinson; Tracy F Uliasz; Valentina Baena; Andreas Geerts; Frank Wunder; Lincoln R Potter; Laurinda A Jaffe
Journal:  Development       Date:  2014-09       Impact factor: 6.868

5.  Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism.

Authors:  Deborah M Dickey; Aaron B Edmund; Neil M Otto; Thomas S Chaffee; Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2016-03-15       Impact factor: 5.157

6.  The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.

Authors:  Jerid W Robinson; Xiaoying Lou; Lincoln R Potter
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  Hypoxia-induced migration in pulmonary arterial smooth muscle cells requires calcium-dependent upregulation of aquaporin 1.

Authors:  Kyle Leggett; Julie Maylor; Clark Undem; Ning Lai; Wenju Lu; Kelly Schweitzer; Landon S King; Allen C Myers; J T Sylvester; Venkataramana Sidhaye; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-08       Impact factor: 5.464

Review 8.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

9.  A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation.

Authors:  Deborah M Dickey; Andrea R Yoder; Lincoln R Potter
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

10.  Dephosphorylation of juxtamembrane serines and threonines of the NPR2 guanylyl cyclase is required for rapid resumption of oocyte meiosis in response to luteinizing hormone.

Authors:  Leia C Shuhaibar; Jeremy R Egbert; Aaron B Edmund; Tracy F Uliasz; Deborah M Dickey; Siu-Pok Yee; Lincoln R Potter; Laurinda A Jaffe
Journal:  Dev Biol       Date:  2015-10-30       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.